233 related articles for article (PubMed ID: 29870976)
61. [24-hour esophageal multichannel intraluminal impedance and pH monitoring].
Kawamura O; Kuribayashi S; Kusano M
Nihon Rinsho; 2016 Aug; 74(8):1285-1292. PubMed ID: 30562430
[TBL] [Abstract][Full Text] [Related]
62. [Non-erosive reflux disease (NERD)].
Kasugai K; Funaki Y; Izawa S; Ogasawara N; Sasaki M
Nihon Rinsho; 2016 Aug; 74(8):1351-1356. PubMed ID: 30562441
[TBL] [Abstract][Full Text] [Related]
63. Endoscopy-negative reflux disease: concepts and clinical practice.
Chey WD
Am J Med; 2004 Sep; 117 Suppl 5A():36S-43S. PubMed ID: 15478851
[TBL] [Abstract][Full Text] [Related]
64. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
[TBL] [Abstract][Full Text] [Related]
65. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring.
Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Furnari M; Martinucci I; Mirante VG; Marchi S; Savarino V; Savarino E
Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27620303
[TBL] [Abstract][Full Text] [Related]
66. Weakly acidic reflux.
Tack J; Blondeau K
Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
[TBL] [Abstract][Full Text] [Related]
67. Proton pump inhibitors relieve and prevent symptoms related to gastric acidity after esophagectomy.
Okuyama M; Motoyama S; Maruyama K; Sasaki K; Sato Y; Ogawa J
World J Surg; 2008 Feb; 32(2):246-54. PubMed ID: 18064513
[TBL] [Abstract][Full Text] [Related]
68. [Non-erosive reflux disease: NERD].
Kasugai K; Funaki Y; Ebi M; Ogasawara N; Sasaki M
Nihon Rinsho; 2015 Jul; 73(7):1105-9. PubMed ID: 26165065
[TBL] [Abstract][Full Text] [Related]
69. A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease.
Dent J; Kahrilas PJ; Hatlebakk J; Vakil N; Denison H; Franzén S; Lundborg P
Am J Gastroenterol; 2008 Jan; 103(1):20-6. PubMed ID: 18184117
[TBL] [Abstract][Full Text] [Related]
70. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.
Kandulski A; Jechorek D; Caro C; Weigt J; Wex T; Mönkemüller K; Malfertheiner P
Aliment Pharmacol Ther; 2013 Sep; 38(6):643-51. PubMed ID: 23895770
[TBL] [Abstract][Full Text] [Related]
71. 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.
Desjardin M; Luc G; Collet D; Zerbib F
Neurogastroenterol Motil; 2016 Jan; 28(1):146-52. PubMed ID: 26526815
[TBL] [Abstract][Full Text] [Related]
72. Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
Okuyama M; Nakahara K; Iwakura N; Hasegawa T; Oyama M; Inoue A; Ishizu H; Satoh H; Fujiwara Y
Digestion; 2017; 95(4):281-287. PubMed ID: 28501868
[TBL] [Abstract][Full Text] [Related]
73. Differences in cerebral response to esophageal acid stimuli and psychological anticipation in GERD subtypes--an fMRI study.
Wang K; Duan LP; Zeng XZ; Liu JY; Xu-Chu W
BMC Gastroenterol; 2011 Mar; 11():28. PubMed ID: 21439078
[TBL] [Abstract][Full Text] [Related]
74. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.
Savarino E; Marabotto E; Zentilin P; Frazzoni M; Sammito G; Bonfanti D; Sconfienza L; Assandri L; Gemignani L; Malesci A; Savarino V
Dig Liver Dis; 2011 Jul; 43(7):542-7. PubMed ID: 21376679
[TBL] [Abstract][Full Text] [Related]
75. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
Pace F; Pace M
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
[TBL] [Abstract][Full Text] [Related]
76. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
77. [The characteristics of esophagogastric junction contractile index in patients with gastroesophageal reflux disease or functional heartburn].
Wang K; Duan LP; Ge Y; Xia ZW; Xu ZJ
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):283-8. PubMed ID: 27030616
[TBL] [Abstract][Full Text] [Related]
78. Esophageal acid sensitivity and mucosal integrity in patients with functional heartburn.
Weijenborg PW; Smout AJ; Bredenoord AJ
Neurogastroenterol Motil; 2016 Nov; 28(11):1649-1654. PubMed ID: 27194216
[TBL] [Abstract][Full Text] [Related]
79. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE
Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
[TBL] [Abstract][Full Text] [Related]
80. Nonerosive reflux disease.
Long JD; Orlando RC
Minerva Gastroenterol Dietol; 2007 Jun; 53(2):127-41. PubMed ID: 17557041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
